¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"granular atrophy of kidney"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • alveolar atrophy
    ÀÌÆ²À§Ãà, Ä¡Á¶À§Ãà
  • back pressure renal atrophy
    ¿ª¾ÐÄáÆÏÀ§Ãà, ¿ª¾Ð½ÅÀåÀ§Ãà
  • correlated atrophy
    »ó°üÀ§Ãà
  • cortical atrophy
    °ÑÁúÀ§Ãà, ÇÇÁúÀ§Ãà
  • choroidal atrophy
    ¸Æ¶ô¸·À§Ãà
  • cicatrical atrophy
    ÈäÅÍÀ§Ãà
  • denervation atrophy
    Å»½Å°æÀ§Ãà
  • disuse atrophy
    ºÒ»ç¿ëÀ§Ãà
  • eccentric atrophy
    Æí½ÉÀ§Ãà
  • facial atrophy
    ¾ó±¼À§Ãà, ¾È¸éÀ§Ãà
  • fat atrophy
    Áö¹æÀ§Ãà
  • geographic atrophy
    Áöµµ¸ð¾çÀ§Ãà
  • geographic retinal atrophy
    Áöµµ¸ð¾ç¸Á¸·À§Ãà
  • juvenile spinal muscular atrophy
    ¼Ò¾ÆÃ´¼ö±Ù(À°)À§ÃàÁõ
  • lactation atrophy
    ¼öÀ¯¼ºÀÚ±ÃÀ§Ãà
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • atrophy
    ˤ̈
  • alveolar atrophy
    ÀÌÆ²À§Ãà, Ä¡Á¶À§Ãà
  • back pressure renal atrophy
    ¿ª¾ÐÄáÆÏÀ§Ãà, ¿ª¾Ð½ÅÀ§Ãà
  • cicatrical atrophy
    ÈäÅÍÀ§Ãà
  • correlated atrophy
    »ó°üÀ§Ãà
  • cortical atrophy
    °ÑÁúÀ§Ãà
  • cyanotic atrophy
    û»öÁõÀ§Ãà
  • denervation atrophy
    Å»½Å°æÀ§Ãà
  • disuse atrophy
    ºÒ»ç¿ëÀ§Ãà
  • eccentric atrophy
    Æí½ÉÀ§Ãà
  • facial atrophy
    ¾ó±¼À§Ãà, ¾È¸éÀ§Ãà
  • fat atrophy
    Áö¹æÀ§Ãà
  • geographic atrophy
    ÁöµµÇüÀ§Ãà
  • halisteretic atrophy
    ŻȸÀ§Ãà
  • lactation atrophy
    ¼öÀ¯À§Ãà, Á¥ºÐºñÀ§Ãà
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inner granular layer
    ³»°ú¸³Ãþ.
  • pharyngitis, granular
    °ú¸³(¼º) Àεο°
  • KUB= kidney, ureter and bladder
    ½Å-´¢°ü-¹æ±¤ ´Ü¼øÃÔ¿µ
  • Kidney
    ½ÅÀå(ãìíô)
  • Kidney
    ÄáÆÏ[½ÅÀå]
  • acquired cystic disease of the kidney
    ÈÄõ¼º ½Å³¶Æ÷Áúȯ
  • adenocarcinoma of kidney
    ½Å¼±¾Ï
  • amyloid kidney
    ¾Æ¹Ð·ÎÀÌµå ½Å
  • artificial kidney
    Àΰø ½ÅÀå(ìÑÍïãìíô)
  • artificial kidney
    Àΰø½ÅÀå.
  • fused kidney
    À¶ÇÕ½Å(ë×ùêãì).
  • glomerular kidney
    Å丮ÄáÆÏ
  • gouty kidney
    Åëdz½Å(÷Ôù¦ãì).
  • head kidney =pronephros
    Àü½Å(îñãì).
  • hemangioma of kidney
    ½ÅÇ÷°üÁ¾.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • granular cell tumor
    °ú¸³¼¼Æ÷Á¾
  • granular corneal dystrophy
    °ú¸³°¢¸·ÀÌ¿µ¾çÁõ.
  • granular endoplasmic reticulum
    °ú¸³ÇüÁú ³»¼¼¸Á, °ú¸³³»ÇüÁú¼¼¸Á.
  • granular endoplasmic reticulum
    °ú¸³¼¼Æ÷Áú¼¼¸Á
  • granular foveolae
    °ú¸³¿À¸ñ
  • granular layer
    °ú¸³Ãþ
  • granular layer
    °ú¸³Ãþ(Ψí£öµ).
  • granular layer
    °ú¸³Ãþ
  • granular layer of dentinal root
    »Ñ¸®»ó¾ÆÁú°ú¸³Ãþ
  • granular leukocyte
    °ú¸³¹éÇ÷±¸
  • granular lutein cell
    °ú¸³ÃþȲ(»ö)ü¼¼Æ÷
  • granular megakaryocyte
    °ú¸³¼º °Å´ëÇÙ¼¼Æ÷
  • granular mitochondria
    °ú¸³Çü »ç¸³Ã¼, °ú¸³ ¼º »ç¸³Ã¼(Ψí£àõÞêí£ô÷).
  • granular pharyngitis
    °ú¸³(¼º) Àεο°
  • granular pits ; foveolae granulares
    °ú¸³¿À¸ñ, °ú¸³¼Ò¿Í.
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • horseshoe kidney
    ¸¶Á¦½Å, ¸¶Á¦Çü½Å
  • kidney
    ½ÅÀå
  • kidney stone
    ½Å°á¼®
  • kidney ureter and bladder [=KUB]
    ½Å-´¢°ü-¹æ±¤ ´Ü¼øÃÔ¿µ
  • kidney, atrophic
    À§Ãà½Å
  • kidney, contracted
    À§Ãà½Å
  • kidney, horseshoe
    ¸¶Á¦Ã¶½Å
  • kidney, polycystic
    ´Ù³¶½Å
  • kidney, rudimentary
    ÈçÀû½Å
  • KUB [=kidney, ureter and bladder]
    ½Å-´¢°ü-¹æ±¤ ´Ü¼øÃÔ¿µ
  • medullary sponge kidney
    ¼öÁú¼ºÇظé(»ó)½Å
  • movable kidney
    À̵¿½Å, À¯ÁÖ½Å
  • percutaneous needle biopsy of kidney
    °æÇǽÅħ»ý°Ë
  • polycystic kidney
    ´Ù³¶½Å
  • solitary kidney
    ´Ü½Å(Áõ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
GER gastroesophageal reflux; geriatrics; granular endoplasmic reticulum
GPC gastric parietal cell; gel permeation chromatography; giant papillary conjunctivitis; glycophorin C;...
LGL-NK large granular lymphocyte-natural killer
LGV large granular vesicle; lymphogranuloma venereum
CK calf kidney; casein kinase; chicken kidney; cholecystokinin; choline kinase; contralateral knee; cre...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LGL Large Granular Lymphocyte
LGL Large granular lymphocytic
LDGL Lymphoproliferative disease of granular lymphocytes
EGL external granular layer
GC granular component
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • kidney nephrotic syndrome
    ½Å ÁõÈıº
  • kidney tuberculosis
    ½Å °áÇÙ
  • medullary sponge kidney
    ¼öÁú¼º ÇØ¸é ½Å, ¼öÁú¼º ÇØ¸é»ó ½Å
  • monkey kidney cell
    ¿ø¼þÀÌ ½Å¼¼Æ÷
  • pelvic kidney
    °ñ¹Ý½Å
    ½ÅÀåÀÌ Á¤»ó À§Ä¡¿¡ ¾ø°í ¼±ÃµÀûÀ¸·Î °ñ¹ÝºÎ¿¡ ÀÖ´Â °ÍÀ» ¸»ÇÑ´Ù.
  • polycystic kidney disease
    ´Ù³¶ ½Å Áúȯ
  • ring shaped kidney
    À±»ó ½Å
  • shock kidney
    ¼îÅ©¼º ½Å ±â´É Àå¾Ö
    ¼îÅ©¿¡ ºüÁ® Ç÷¾Ð ÀúÇϰ¡ ±æ°Ô À̾îÁ® ½Å Ç÷·ù·®ÀÌ °¨¼ÒÇÏ¿© »ý±ä ±Þ¼º ½Å ºÎÀü.
  • sigmoid kidney
    ¿¡½ºÀÚ»ó ½Å
    ÇÑÂÊ ½ÅÀÚÀÇ »ó±ØÀÌ ´Ù¸¥ ÂÊ ½ÅÀåÀÇ Çϱذú À¶ÇÕµÈ º¯Çü À¶ÇÕ ½Å.
  • solitary kidney
    ´Ü½Å, ´Ü½ÅÁõ
  • transplantation of kidney
    ¸é¿ª ½Å À̽Ä
    µ¿ÀǾî=renal trans
  • trifid kidney
    »ï¿­ ½Å
  • tumors of the kidney
    ½ÅÀå Á¾¾ç
    ½ÅÀå¿¡ ¹ß»ýÇÏ´Â Á¾¾ç. ¾Ç¼ºÀÎ °ÍÀÌ ¸¹À¸¸ç, ±× ´ëºÎºÐÀº ±×¶óºñÃ÷ Á¾¾çÀ̶ó ÇÏ´Â ½Å ½ÇÁú¿¡ »ý±â´Â ¼±¾ÏÀÌ´Ù. ÀÌ ¹Û¿¡ ½Å¿ì¿¡ »ý±â´Â À¯µÎÁ¾À̳ª À¯À¯¾Æ¿¡ »ý±â´Â ºô¸§½º Á¾¾ç µîÀÌ ÀÖ´Ù. ÁÖ¿ä Áõ¼¼·Î´Â ÀϹÝÀûÀ¸·Î Ç÷´¢, Á¾·ù, ½ÅºÎ µ¿ÅëÀÇ 3°¡ÁöÀÌÁö¸¸, ¹ß¿­À̳ª ±âħ, ±× ¹Û¿¡ ¿©·¯ °¡Áö Àü½Å Áõ¼¼·Î ½ÃÀ۵Ǵ °Íµµ ¸¹´Ù. ½Å¿ì ÃÔ¿µ, ½Åµ¿¸Æ ÃÔ¿µ µîÀ¸·Î Áø´ÜÇÑ´Ù. Ä¡·á´Â °¡±ÞÀûÀ̸é Á¶±â¿¡ ¹ß°ßÇÏ¿© ½ÅÀåÀ» ÀûÃâÇÏ°í ´ÙÀ½¿¡ ¹æ»ç¼± ¿ä¹ýÀ» ¾´´Ù. ºô¸§½º Á¾¾ç¿¡´Â ¾ÇƼ³ë¸¶À̽ŠDÀÇ Ç×¾ÏÁ¦°¡ À¯È¿ÇÏ´Ù.
  • vein of kidney
    ÄáÆÏ Á¤¸Æ
  • age atrophy
    ³ëÀμº ÅðÃà
    ³ªÀ̰¡ µê¿¡ µû¸¥ ¸ðµç Á¶Á÷ÀÇ »ý¸®ÀûÀÎ °¨¼Ò.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
granular layers of retina The outer nuclear layer, layer 4, of the retina, neuroepithelial layer of retina, and the inner layer, layer 6, of the retina, ganglionic layer of retina.
Synonym: granular layers of retina, stratum nucleare externum et internum retinae.
(05 Mar 2000)
granular leukoblast An obsolete term for promyelocyte.
(05 Mar 2000)
granular leukocyte Any one of the polymorphonuclear leukocyte's, especially a neutrophilic leukocyte.
See: granulocyte, basophilic leukocyte, eosinophilic leukocyte.
(05 Mar 2000)
granular lids <ophthalmology> A chronic infectious disease of the conjunctiva and cornea, producing photophobia, pain, lacrimation and blindness.
It is one of the oldest infectious diseases known to mankind, and dates back several thousand years with first documentation as early as the pharaonic era in Egypt.
The disease is associated with poor socioeconomic conditions in general: with overcrowding, poor personal and environmental hygiene and, in particular, with very limited access to water and sanitation. Trachoma has been eliminated as a blinding disease from several previously hyperendemic countries and regions, both through significant improvements in the socioeconomic status of populations and through specific control efforts.
Despite these successes, in many least developed countries of the world blinding trachoma continues to be an important public health problem. In some of the countries where trachoma was once hyperendemic, there remain residual pockets of blinding trachoma and complications, such as inturned eyelashes (trichiasis), which require eyelid surgery.
Today, the disease is found mainly in poor rural areas, including parts of central and south America, most African countries and some countries in the Eastern Mediterranean. Trachoma is still endemic in several Asian countries, but there is a lack of updated information from some major populations, e.g. In India and China.
The organism that causes this disease is Chlamydia trachomatis; a microorganism resembling both bacteria and viruses, which spreads through contact with eye discharge from the infected person (on towels, handkerchiefs, fingers, etc.) and through transmission by eye-seeking flies. Chlamydia trachomatis provokes an inflammatory reaction in the eye with formation of follicles in the conjunctiva. After years of repeated infections, the inside of the eyelids may be scarred so severely that the eyelid turns inwards with eyelashes rubbing on the eyeball. If untreated, this condition leads to blindness.
The World Health Organization is working towards global elimination of trachoma, which is responsible, at present, for at least 15% of the world's blindness. Worldwide, there are about 6 million people largely irreversibly blinded by trachoma, and an estimated 146 million cases of active disease in need of treatment, if blindness is to be prevented.
International efforts to eliminate trachoma as a blinding disease will be based on a combination of interventions known by the acronym "SAFE", which stands for Surgery for trichiasis (inturned eyelashes), Antibiotics, Facial cleanliness and Environmental improvement. These interventions will be community-targeted and will seek community involvement through the primary health care approach.
Origin: Gr. Trachoma = roughness
(07 May 1998)
granular ophthalmia <ophthalmology> A chronic infectious disease of the conjunctiva and cornea, producing photophobia, pain, lacrimation and blindness.
It is one of the oldest infectious diseases known to mankind, and dates back several thousand years with first documentation as early as the pharaonic era in Egypt.
The disease is associated with poor socioeconomic conditions in general: with overcrowding, poor personal and environmental hygiene and, in particular, with very limited access to water and sanitation. Trachoma has been eliminated as a blinding disease from several previously hyperendemic countries and regions, both through significant improvements in the socioeconomic status of populations and through specific control efforts.
Despite these successes, in many least developed countries of the world blinding trachoma continues to be an important public health problem. In some of the countries where trachoma was once hyperendemic, there remain residual pockets of blinding trachoma and complications, such as inturned eyelashes (trichiasis), which require eyelid surgery.
Today, the disease is found mainly in poor rural areas, including parts of central and south America, most African countries and some countries in the Eastern Mediterranean. Trachoma is still endemic in several Asian countries, but there is a lack of updated information from some major populations, e.g. In India and China.
The organism that causes this disease is Chlamydia trachomatis; a microorganism resembling both bacteria and viruses, which spreads through contact with eye discharge from the infected person (on towels, handkerchiefs, fingers, etc.) and through transmission by eye-seeking flies. Chlamydia trachomatis provokes an inflammatory reaction in the eye with formation of follicles in the conjunctiva. After years of repeated infections, the inside of the eyelids may be scarred so severely that the eyelid turns inwards with eyelashes rubbing on the eyeball. If untreated, this condition leads to blindness.
The World Health Organization is working towards global elimination of trachoma, which is responsible, at present, for at least 15% of the world's blindness. Worldwide, there are about 6 million people largely irreversibly blinded by trachoma, and an estimated 146 million cases of active disease in need of treatment, if blindness is to be prevented.
International efforts to eliminate trachoma as a blinding disease will be based on a combination of interventions known by the acronym "SAFE", which stands for Surgery for trichiasis (inturned eyelashes), Antibiotics, Facial cleanliness and Environmental improvement. These interventions will be community-targeted and will seek community involvement through the primary health care approach.
Origin: Gr. Trachoma = roughness
(07 May 1998)
granular pits Pits on the inner surface of the skull, along the course of the superior sagittal sinus, in which are lodged the arachnoidal granulations.
Synonym: foveolae granulares, pacchionian depressions.
(05 Mar 2000)
granular pneumonocytes Cuboidal cell's connected with the squamous pulmonary alveolar cell's and having in their cytoplasm lamellated bodies (cytosomes) that represent the source of the surfactant that coats the alveoli.
Synonym: granular pneumonocytes, type II cells.
(05 Mar 2000)
granular trachoma <ophthalmology> The ordinary form of trachoma marked by the presence of granulations on the conjunctiva.
Synonym: granular trachoma.
(05 Mar 2000)
granular urethritis <urology> Chronic urethritis with nodular lymphocytic infiltrations in the mucosa.
Synonym: granular urethritis.
(05 Mar 2000)
granular vaginitis A condition of cattle manifested by the appearance of small, spherical, transparent nodules in the mucosa of the vagina of cows and of the penis of bulls; the mucosa is reddened and a mucopurulent exudate appears on the affected surfaces; it is a non specific hyperplastic response of the lymphatic tissue of these areas to an irritant or an antigen.
(05 Mar 2000)
Tomes' granular layer <dentistry> A thin layer of dentin adjacent to the cementum, appearing granular in ground sections; the granules are small uncalcified spaces.
(05 Mar 2000)
acute reflex bone atrophy Atrophy of bones, commonly of the carpal or tarsal bones, following a slight injury such as a sprain.
See: causalgia, reflex sympathetic dystrophy.
Synonym: acute reflex bone atrophy, posttraumatic osteoporosis, Sudeck's syndrome.
Origin: L. English sweat
(05 Mar 2000)
acute yellow atrophy of the liver A lesion in which there is extensive and rapid death of parenchymal cells of the liver, sometimes with fatty degeneration of the size of the organ; the necrosis may result from fulminant viral infection or chemical poisoning; associated with jaundice.
Synonym: acute parenchymatous hepatitis, Rokitansky's disease.
(05 Mar 2000)
alveolar atrophy Diminution in size of the supportive tissues of the teeth due to lack of function, reduced blood supply, or unknown causes.
(05 Mar 2000)
arthritic atrophy Atrophy of muscles rendered inactive by a chronically inflamed or fixed joint.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á